Remote Assesment of Functional Sequelae in Patients Operated for Congenital Syndactyly (DISTSSEQUELO)

May 18, 2026 updated by: University Hospital, Lille

Evaluation of the Gilbert Dorsal Commissural Flap in the Managment of Congenital Syndactylies

The aim of th study is to evaluate patients who have been operated for congenital syndactylies. The surgical technique has evolved, and the donnor site for the total skin graft is not the same than 10 years ago. Furthermore, the investigators want to evaluate the function of the hand and the evolution of the operated web space. The patient is examined in consultation by the same doctor, the investigator list complications and evolution of the hand. the investigators also ask the patient and his parents about the satisfaction of the surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

37

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Lille, France
        • CHU de LILLE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Il s'agit d'une cohorte de patients opérés d'une syndactylie congénitale des doigts longs. On étudie ici la rétraction commissurale et les séquelles fonctionnelles et esthétiques, avec greffe de peau totale prélevée au niveau du pli du poignet.

Description

Inclusion Criteria:

  • operated between 2005 and 2019 at Lille University Hospital.
  • born between 2003 and 2020.
  • With congenital syndactyly (ies) of the upper limb.
  • Syndromic or non syndromic congenital syndactyly of the upper of the long fingers.

Exclusion Criteria:

  • Patients operated on before 2005 or after 2020

    • Acquired syndactyly (post-traumatic)
    • Syndactyly (ies) of the lower limb.
    • congenital syndactyly of the first webspace
    • Impossible to obtain consent from parents or patients or refusal
    • Unable to travel to Lille University Hospital for the consultation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Consultation
Patients will be called in for consultation in the CHU de Lille to be examined.
Other: Consultation
Patients will be called in for consultation in the CHU de Lille to be examined.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Study of the retraction of the webspace with Withey scale
Time Frame: From 4 years to 18 years after the surgery
From 4 years to 18 years after the surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Evaluation of the scars with Vancouver scale.
Time Frame: From 4 years to 18 years after the surgery
From 4 years to 18 years after the surgery

Other Outcome Measures

Outcome Measure
Time Frame
Evaluation of the scar from the donor site of the total skin graft with Vancouver scale.
Time Frame: 4 years to 18 years after the surgery
4 years to 18 years after the surgery
Study of the flessum with a goniometer.
Time Frame: 4 years to 18 years after the surgery
4 years to 18 years after the surgery
Study of the clinodactyly with a goniometer.
Time Frame: 4 years to 18 years after the surgery
4 years to 18 years after the surgery
Study of the patients and parents satisfaction with a Likert scale.
Time Frame: 4 years to 18 years after the surgery
4 years to 18 years after the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2023

Primary Completion (Actual)

December 1, 2024

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

November 13, 2023

First Submitted That Met QC Criteria

May 18, 2026

First Posted (Actual)

May 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020_88
  • 2021-A02023-38 (Other Identifier: ID-RCB number, ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Syndactyly

Clinical Trials on Consultation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe